Ingredients & DescriptionAcid-A-Cal contains compounds, vitamins, and minerals which may help to maintain balanced pH levels within the body. Abnormal acid-alkaline levels contribute to a number of abdominal discomforts. More importantly, unbalanced pH levels prevent the natural absorption of calcium.
Enzamatic Therapy's Acid-A-Cal is formulated to help the body maintain a proper pH balance. Acid-A-Cal may normalize your acid-alkaline levels and promote natural calcium absorption. Calcium, as we all know, is a nutrient essentail for bone health and strength.
Recommendations: Two capsules with each meal and at bedtime.
Serving Size: 2 Capsules
Serving Per Container: 50 (100 Capsules)
|Vitamin C (ascorbic acid and from rose hips)||100 mg||167 %|
|Vitamin B6 (as pyridoxine HCl)||50 mg||2,500 %|
|Calcium (as calcium chloride and dicalcium phosphate)||108 mg||11 %|
|Magnesium (as magnesium glycerophosphate)||11 mg||3 %|
|Betaine HCl||192 mg||*|
|Ammonium Chloride||192 mg||*|
Lemon (Citrus x limon)
|Other Ingredients:gelatin, cellulose, silicon dioxide, magnesium stearate, and titanium dioxide color.|
*Daily Value (DV) not established.
Contains No: sugar, salt, yeast, wheat, gluten, corn, soy, dairy products, artificial flavoring and preservatives. All colors used are from natural sources.
Notes: All organs and glands derived from bovine sources.
Keep bottle tightly closed. This product attracts moisture.
*Not intended to diagnose or treat diseases or ailments, and is not reviewed by the FDA.Uses & Indications.
In a cohort of 44 patients with RA, 25-hydroxyvitamin D3 [25(OH)D3] levels, parathyroid hormone levels, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were measured. Disease activity was evaluated by calculating the 28-joint Disease Activity Score (DAS28). A control group (n = 44), matched for age and sex, was evaluated as well.
In the cohort of 44 patients with RA 25(OH)D3 levels were found to be low compared with the control group, 25(OH)D3 being 15.26 ± 1.07 ng/ml [mean ± standard error of the mean (SEM)] and 25.8 ± 1.6 ng/ml in the patient and control group respectively (Student’s t test, p < 0.001). Parathyroid hormone levels were 71.08 ± 7.02 pg/ml (mean ± SEM) (normal values 10.0–65.0 pg/ml), CRP 7.6 ± 1.57 mg/litre (mean ± SEM) (normal values < 3 mg/litre) and ESR was 38.0 ± 4.6 mm/h (mean ± SEM) in the group of patients with RA. Levels of 25(OH)D3 were found to be negatively correlated to the DAS28, the correlation coefficient being −0.084. Levels of 25(OH)D3 were also found to be negatively correlated to CRP and ESR, the correlation coefficient being –0.115 and −0.18, respectively.
It appears that vitamin D deficiency is highly prevalent in patients with RA, and that vitamin D deficiency may be linked to disease severity in RA. As vitamin D deficiency has been linked to diffuse musculoskeletal pain, these results have therapeutic implications. Vitamin D supplementation may be needed both for the prevention of osteoporosis as well as for pain relief in patients with RA. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539179/ Seacoast conclusion Though the study did show that the overall RA patients had low vitamin D levels, the study only contained 44 patients thus larger studies should be done to further confirm this theory. To view some of our Vitamin D supplements, if you are interested, please see below. http://www.seacoast.com/vitamin-d